Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma
Open Access
- 17 April 2003
- Vol. 97 (9) , 2203-2211
- https://doi.org/10.1002/cncr.11311
Abstract
BACKGROUND There is a statistically significant association between human leukocyte antigen (HLA) Class I antigen expression and improved prognosis for some patients. This association reflects the control of tumor growth by HLA Class I antigen‐restricted, tumor‐associated antigen‐specific cytolytic T cells. However, progression of other malignant diseases is not associated with the loss of HLA expression. These observations show that the poor prognosis of a subset of tumors, despite high HLA Class I antigen expression, may reflect the development of alternative mechanisms utilized by tumor cells to escape from immune recognition and destruction. METHODS The authors evaluated the possible correlation between the expression of the antiapoptosis gene, Survivin, HLA Class I, and progression of tonsillar squamous cell carcinomas (TSCC) lesions. Tissue microarrays were constructed from primary TSCC, metastatically involved lymph nodes, adjacent normal mucosa, and tonsillar parenchyma excised for nonmalignant conditions. RESULTS Immunoperoxidase staining of tissue sections demonstrated that Survivin expression is significantly higher (P < 0.001) in malignant tumors than in normal tissue samples. In addition, Survivin expression is significantly higher (P = 0.05) in metastatic than in primary lesions. Survivin expression in primary lesions correlated positively with delta (P = 0.025), tapasin (P = 0.028), and HLA Class I antigen (P = 0.006) expression. The expression patterns of delta, tapasin, HLA Class I antigen, β‐2‐microglobulin, and Survivin did not demonstrate any significant association with the clinical course of disease. CONCLUSIONS For TSCC that maintain the expression of HLA Class I antigen, overexpression of Survivin may provide an alternative explanation for tumor progression. Cancer 2003;97:2203–11. © 2003 American Cancer Society. DOI 10.1002/cncr.11311Keywords
This publication has 19 references indexed in Scilit:
- Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasionNature Medicine, 2002
- Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasionNature Medicine, 2002
- MHC class I negative phenotype of disseminated tumor cells in bone marrow is associated with poor survival in R0M0 breast cancer patients.International Journal of Cancer, 2001
- Expression of the Apoptosis Inhibitor Survivin in Aggressive Squamous Cell CarcinomaExperimental and Molecular Pathology, 2001
- Immunohistochemical Detection of the Anti-Apoptosis Protein, Survivin, Predicts Survival After Curative Resection of Stage II Colorectal CarcinomasAnnals of Surgical Oncology, 2001
- Urine Detection of Survivin and Diagnosis of Bladder CancerJAMA, 2001
- Expression of the Novel Inhibitor of Apoptosis Survivin in Normal and Neoplastic SkinJournal of Investigative Dermatology, 1999
- Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease?Current Opinion in Oncology, 1999
- Cancer vaccinesNature Medicine, 1998
- HLA Class I and Class II Antigen Expression on Squamous Cell Carcinoma of the Head and NeckJAMA Otolaryngology–Head & Neck Surgery, 1990